These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 6413114

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 4. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
    Sessa C, D'Incalci M, Valente I, Bolis G, Colombo N, Mangioni C.
    Cancer Treat Rep; 1982 May 15; 66(5):1233-4. PubMed ID: 6805951
    [No Abstract] [Full Text] [Related]

  • 5. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
    Israël L, Lepage E, Breau JL, Aguilera J.
    Bull Cancer; 1982 May 15; 69(5):426-33. PubMed ID: 6891902
    [Abstract] [Full Text] [Related]

  • 6. Modulation and intensification of a cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin ovarian cancer regimen.
    Bruckner HW, Cohen CJ, Feuer E, Holland JF.
    Obstet Gynecol; 1989 Mar 15; 73(3 Pt 1):349-56. PubMed ID: 2492648
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of advanced ovarian cancer].
    de Gramont A, Krulik M, Pigne A, Brissaud P, Sirinelli A, Hubert D, Zylberait D, Debray J.
    Sem Hop; 1984 Mar 29; 60(14):957-60. PubMed ID: 6326283
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.
    Pater JL, Carmichael JA, Krepart GV, Fraser RC, Roy M, Kirk ME, Levitt M, Brown LB, Wilson KS, Shelley WE.
    Cancer Treat Rep; 1987 Mar 29; 71(3):277-81. PubMed ID: 3102056
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
    Pasmantier MW, Coleman M, Silver RT, Ballard WP.
    Cancer Treat Rep; 1985 Jun 29; 69(6):689-93. PubMed ID: 3926310
    [Abstract] [Full Text] [Related]

  • 14. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
    Ehrlich CE, Einhorn L, Stehman FB, Blessing J.
    Clin Obstet Gynaecol; 1983 Aug 29; 10(2):325-35. PubMed ID: 6688562
    [No Abstract] [Full Text] [Related]

  • 15. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
    Piver MS, Lele S, Barlow JJ.
    Cancer Treat Rep; 1981 Aug 29; 65(1-2):149-51. PubMed ID: 6784921
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T, Vance R, Puneky L, Khansur T.
    Gynecol Oncol; 1994 Dec 29; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [Abstract] [Full Text] [Related]

  • 17. Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.
    Neijt JP, van Lindert AC, Vendrik CP, Roozendaal KJ, Struyvenberg A, Pinedo HM.
    Neth J Med; 1979 Dec 29; 22(2):38-44. PubMed ID: 107464
    [No Abstract] [Full Text] [Related]

  • 18. [Chemotherapy of epithelial ovarian carcinoma].
    Bruntsch U, Gallmeier WM.
    MMW Munch Med Wochenschr; 1983 Nov 04; 125(44):993-5. PubMed ID: 6417517
    [No Abstract] [Full Text] [Related]

  • 19. Mayo Clinic experience with epithelial ovarian cancer.
    Decker DG.
    Clin Obstet Gynaecol; 1983 Aug 04; 10(2):337-56. PubMed ID: 6413115
    [Abstract] [Full Text] [Related]

  • 20. Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operation.
    Greco FA, Julian CG, Richardson RL, Burnett L, Hande KR, Oldham RK.
    Obstet Gynecol; 1981 Aug 04; 58(2):199-205. PubMed ID: 6789265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.